Some immune cells in our bodies see their "killer instinct" restricted after entering solid tumors, according to new research.
Feb 2, 2024
0
88
Natural killer (NK) cells, part of the innate immune system, can permanently remain in infected tissue and thus contribute to immunological memory, researchers at the University of Würzburg have discovered.
Jan 9, 2024
0
20
Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease in which the Epstein-Barr virus (EBV) is thought to play a role that has not yet been fully clarified. In particular, it was previously unclear why almost ...
Dec 14, 2023
0
48
Cancer immunotherapy primes a patient's immune system to better find and destroy cancer cells, improving upon the body's natural ability to fight tumors. Contemporary immunotherapy approaches aim to stimulate immune cells ...
Dec 11, 2023
0
0
In a recent study published in Leukemia, Finnish researchers investigated why some patients with chronic myeloid leukemia (CML) can discontinue their daily medication safely.
Nov 6, 2023
0
0
The Wistar Institute's David B. Weiner and collaborators have engineered novel monoclonal antibodies that engage natural killer (NK) cells through a unique surface receptor that activates the immune system to fight against ...
Nov 1, 2023
0
21
Researchers from UNSW Sydney and Stanford University have shown that dengue virus can disrupt the immune system in children, leading to more severe disease. These changes in the immune system, referred to as "immune confusion," ...
Oct 31, 2023
0
17
Introducing medical devices—commonly made of materials such as titanium, silicone, or collagen—into our bodies can elicit a host of different immune responses. While some responses can harm our bodies, others can help ...
Oct 24, 2023
0
14
Immune cells play a key role during pregnancy, adjusting immune system response in a way that enables the fetus to develop while also protecting the parent and fetus from outside assaults like viruses. In a new study, Yale ...
Oct 10, 2023
0
1
Researchers at Vanderbilt-Ingram Cancer Center have discovered a drug target on natural killer cells that could potentially trigger a therapeutic response in patients with immunotherapy-resistant, triple-negative breast cancer.
Oct 4, 2023
0
1
